MEI Pharma Inc.

USPTO Trademark & Patent Filings

Mei Pharma Inc

Trademark applications and grants for Mei Pharma Inc.. Mei Pharma Inc. has 4 trademark applications. The latest application filed is for "KIMBRIX THERAPEUTICS"

Company Profile
    Company Aliases
  • MEI Pharma Inc.
  • MEI Pharma, Inc. - San Diego CA US
State Incorporated DELAWARE
Entity Type CORPORATION
Address 11455 El Camino Real, Suite 250 San Diego, CALIFORNIA UNITED STATES 92130

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks Patents
Patent Applications
Patent ApplicationDate
COMBINATION THERAPY
20220265673 - 17/734345 GOLD; Daniel P.
2022-08-25
COMBINATION THERAPY
20220193086 - 17/684306 GOLD; Daniel P.
2022-06-23
COMBINATION THERAPIES FOR HIGH AND VERY HIGH RISK MDS
20220016082 - 17/294513 GHALIE; Richard
2022-01-20
ISOFLAVONOID COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER
20210361614 - 17/193335 MORENO; Ofir
2021-11-25
TREATMENT OF B CELL MALIGNANCIES
20210299134 - 17/268052 GOLD; Daniel P.
2021-09-30
Patent Grants & Applications
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed